Case 1:18-cv-00924-CFC Document 334 Filed 07/29/19 Page 1 of 8 PageID #: 25862
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`GENENTECH, INC. and CITY OF HOPE,
`
`
`
`v.
`
`AMGEN, INC.,
`
`
`
`
`
`
`
`
`
`
`
`
`
`Plaintiffs,
`
`Defendant.
`
`
`
`
`
`C.A. No. 1:18-cv-00924-CFC
`
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`GENENTECH’S FED. R. CIV. P. 62(d) MOTION FOR AN INJUNCTION
`PENDING APPEAL, OR, IN THE ALTERNATIVE, A 14-DAY INJUNCTION
`TO ENABLE GENENTECH TO PURSUE AN EXPEDITED MOTION FOR AN
`INJUNCTION PENDING APPEAL BEFORE THE FEDERAL CIRCUIT
`PURSUANT TO FED. R. APP. P. 8
`
`Plaintiff Genentech, Inc., by and through their undersigned counsel, respectfully seek an
`
`Order enjoining defendant Amgen, Inc. from commercially launching, marketing or selling its
`
`trastuzumab biosimilar product, Kanjinti, pending appeal of the Court’s July 18, 2019 Order
`
`(D.I. 300), or, in the alternative, a 14-day injunction to enable Genentech to pursue an expedited
`
`motion for an injunction pending appeal before the Federal Circuit pursuant to Fed. R. App. P. 8.
`
`The grounds for Plaintiffs’ motion are set forth in Genentech’s Opening Brief in Support
`
`of Its Fed. R. Civ. P. R. 62(d) Motion for an Injunction Pending Appeal, or, in the Alternative, a
`
`14-Day Injunction to Enable Genentech to Pursue an Expedited Motion for an Injunction
`
`Pending Appeal Before the Federal Circuit Pursuant to Fed. R. App. P. 8., as well as its
`
`previously-filed briefs in support of its emergency motions for temporary restraining order and
`
`preliminary injunction (D.I. 275, 292), Declarations in Support, and accompanying exhibits. A
`
`Proposed Order is filed contemporaneously herewith.
`
`
`ME1 30986183v.1
`
`PUBLIC VERSION FILED:
`JULY 29, 2019
`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`GENENTECH, INC. and CITY OF HOPE,
`
`
`
`v.
`
`AMGEN, INC.,
`
`
`
`
`
`
`
`
`
`
`
`
`
`Plaintiffs,
`
`Defendant.
`
`
`
`
`
`C.A. No. 1:18-cv-00924-CFC
`
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`GENENTECH’S FED. R. CIV. P. 62(d) MOTION FOR AN INJUNCTION
`PENDING APPEAL, OR, IN THE ALTERNATIVE, A 14-DAY INJUNCTION
`TO ENABLE GENENTECH TO PURSUE AN EXPEDITED MOTION FOR AN
`INJUNCTION PENDING APPEAL BEFORE THE FEDERAL CIRCUIT
`PURSUANT TO FED. R. APP. P. 8
`
`Plaintiff Genentech, Inc., by and through their undersigned counsel, respectfully seek an
`
`Order enjoining defendant Amgen, Inc. from commercially launching, marketing or selling its
`
`trastuzumab biosimilar product, Kanjinti, pending appeal of the Court’s July 18, 2019 Order
`
`(D.I. 300), or, in the alternative, a 14-day injunction to enable Genentech to pursue an expedited
`
`motion for an injunction pending appeal before the Federal Circuit pursuant to Fed. R. App. P. 8.
`
`The grounds for Plaintiffs’ motion are set forth in Genentech’s Opening Brief in Support
`
`of Its Fed. R. Civ. P. R. 62(d) Motion for an Injunction Pending Appeal, or, in the Alternative, a
`
`14-Day Injunction to Enable Genentech to Pursue an Expedited Motion for an Injunction
`
`Pending Appeal Before the Federal Circuit Pursuant to Fed. R. App. P. 8., as well as its
`
`previously-filed briefs in support of its emergency motions for temporary restraining order and
`
`preliminary injunction (D.I. 275, 292), Declarations in Support, and accompanying exhibits. A
`
`Proposed Order is filed contemporaneously herewith.
`
`
`ME1 30986183v.1
`
`PUBLIC VERSION FILED:
`JULY 29, 2019
`
`
`
`Case 1:18-cv-00924-CFC Document 334 Filed 07/29/19 Page 2 of 8 PageID #: 25863
`
`
`
`
`
`Respectfully Submitted,
`
`
`/s/ Daniel M. Silver
`Michael P. Kelly (#2295)
`Daniel M. Silver (#4758)
`MCCARTER & ENGLISH, LLP
`Renaissance Centre
`405 North King Street, 8th Floor
`Wilmington, DE 19801
`(302) 984-6300
`mkelly@mccarter.com
`dsilver@mccarter.com
`
`Attorneys for Genentech, Inc. and
`City of Hope
`
`
`
`Of Counsel:
`
`William F. Lee
`Lisa J. Pirozzolo
`Emily R. Whelan
`Kevin S. Prussia
`Andrew J. Danford
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`60 State Street
`Boston, MA 02109
`(627) 526-6000
`william.lee@wilmerhale.com
`lisa.pirozzolo@wilmerhale.com
`emily.whelan@wilmerhale.com
`kevin.prussia@wilmerhale.com
`andrew.danford@wilmerhale.com
`
`Robert J. Gunther Jr.
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`(212) 230-8800
`robert.gunther@wilmerhale.com
`
`Daralyn J. Durie
`Adam R. Brausa
`DURIE TANGRI LLP
`217 Leidesdorff St.
`San Francisco, CA 94111
`(415) 362-6666
`ddurie@durietangri.com
`abrausa@durietangri.com
`
` Dated: July 19, 2019
`
`
`
`ME1 30986183v.1
`
`2
`
`
`
`Case 1:18-cv-00924-CFC Document 334 Filed 07/29/19 Page 3 of 8 PageID #: 25864
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`GENENTECH, INC. and CITY OF HOPE,
`
`
`
`v.
`
`AMGEN, INC.,
`
`
`
`
`
`
`
`
`
`
`
`
`
`Plaintiffs,
`
`Defendant.
`
`
`
`
`
`C.A. No. 1:18-cv-00924-CFC
`
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`
`[PROPOSED] ORDER GRANTING GENENTECH’S EMERGENCY MOTION FOR
`PRELIMINARY INJUNCTION
`
`IT IS HEREBY ORDERED on this __________ day of _________________, 2019, that:
`
`1. Genentech’s motion for an injunction pending resolution of Genentech’s appeal
`
`of the Court’s Order denying Genentech’s motions for preliminary and temporary injunctive
`
`relief is granted.
`
`OR
`
`Genentech’s motion for a 14-day injunction to allow it to pursue an expedited motion for
`
`injunctive relief before the Court of Appeals is granted. The injunction shall expire in fourteen
`
`(14) days from this Order or when the Court of Appeals grants or denies injunctive relief,
`
`whichever happens first.
`
`2. Accordingly, defendant Amgen Inc., its affiliates, subsidiaries, and each of its
`
`officers, agents, servants and employees, and those acting in privity or in concert with them, is
`
`prohibited from commercially marketing Kanjinti within the United States, until this Court
`
`renders a decision on the merits of Genentech’s patent infringement claims following trial, and
`
`until the Court of Appeals for the Federal Circuit has adjudicated any appeal of that decision.
`
`
`ME1 30986222v.1
`
`PUBLIC VERSION FILED:
`JULY 29, 2019
`
`
`
`Case 1:18-cv-00924-CFC Document 334 Filed 07/29/19 Page 4 of 8 PageID #: 25865
`
`
`
`3. Amgen shall provide notice of this Order within three (3) days to any affiliates,
`
`subsidiaries, and each of their officers, agents, servants and employees, and those acting in
`
`privity or in concert with them that is involved in any effort to market Kanjinti commercially
`
`within the United States.
`
`4. Genentech shall post an unsecured bond in the amount of $______ (_____
`
`dollars) within seven (7) days of the entry of this Order. Genentech shall act as its own surety
`
`for such bond.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`____________________________
`The Honorable Colm F. Connolly
`United States District Judge
`
`ME1 30986222v.1
`
`2
`
`
`
`Case 1:18-cv-00924-CFC Document 334 Filed 07/29/19 Page 5 of 8 PageID #: 25866
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`
`
`
`C.A. No. 18-924-CFC
`
`
`
`
`
`
`Plaintiffs,
`
`Defendant.
`
`
`GENENTECH, INC. and CITY OF HOPE,
`
`
`
`v.
`
`AMGEN, INC.,
`
`
`
`
`
`
`
`
`
`
`
`
`
`AVERMENT OF COUNSEL
`
`
`
`The undersigned counsel hereby certifies that counsel for Plaintiffs conferred with
`
`counsel for Defendant, including verbally in one or more teleconferences involving Delaware
`
`counsel for all parties, regarding the relief sought in the foregoing motion and that counsel were
`
`unable to reach agreement on the relief sought.
`
`
`
`Case 1:18-cv-00924-CFC Document 334 Filed 07/29/19 Page 6 of 8 PageID #: 25867
`
`
`
`
`
`MCCARTER & ENGLISH LLP
`
`
`/s/ Daniel M. Silver
`Michael P. Kelly (#2295)
`Daniel M. Silver (#4758)
`Alexandra M. Joyce (#6423)
`Renaissance Centre
`405 N. King Street, 8th Floor
`Wilmington, Delaware 19801
`Tel.: (302) 984-6300
`Fax: (302) 984-6399
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`Attorneys for Plaintiffs Genentech,
`Inc. and City of Hope
`
`Date: July 19, 2019
`
`Of Counsel:
`
`William F. Lee
`Lisa J. Pirozzolo
`Emily R. Whelan
`Kevin Prussia
`Andrew J. Danford
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`60 State Street
`Boston, MA 02109
`(627) 526-6000
`william.lee@wilmerhale.com
`lisa.pirozzolo@wilmerhale.com
`emily.whelan@wilmerhale.com
`kevin.prussia@wilmerhale.com
`andrew.danford@wilmerhale.com
`
`Robert J. Gunther Jr.
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`(212) 230-8800
`robert.gunther@wilmerhale.com
`
`Daralyn J. Durie
`Adam R. Brausa
`DURIE TANGRI LLP
`217 Leidesdorff St.
`San Francisco, CA 94111
`(415) 362-6666
`ddurie@durietangri.com
`abrausa@durietangri.com
`
`
`2
`
`
`
`Case 1:18-cv-00924-CFC Document 334 Filed 07/29/19 Page 7 of 8 PageID #: 25868
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned counsel hereby certifies that true and correct copies of the foregoing
`
`document were caused to be served on July 19, 2019 on the following counsel in the manner
`
`indicated:
`
`
`VIA EMAIL:
`
`Neal C. Belgam
`Eve H. Ormerod
`Jennifer M. Rutter
`SMITH, KATZENSTEIN & JENKINS, LLP
`1000 West Street, Suite 1501
`Wilmington, DE 19801
`(302) 652-8400
`nbelgam@skjlaw.com
`eormerod@skjlaw.com
`jrutter@skjlaw.com
`
`
`Orion Armon
`COOLEY, LLP
`380 Interlocken Crescent, Suite 900
`Broomfield, CO 80021-8023
`(720) 566-4119
`oarmon@cooley.com
`
`
`Eamonn Gardner
`COOLEY, LLP
`4401 Eastgate Mall
`San Diego, CA 92121-1909
`(858) 550-6086
`egardner@cooley.com
`
`
`
`
`
`
`
`
`
`
`
`ME1 30984067v.1
`
`
`
`Case 1:18-cv-00924-CFC Document 334 Filed 07/29/19 Page 8 of 8 PageID #: 25869
`
`
`
`Michelle Rhyu
`Susan Krumplitsch
`Daniel Knauss
`Philip H. Mao
`Alexandra Leeper
`Lauren Krickl
`Benjamin S. Lin
`Alissa M. Wood
`COOLEY, LLP
`3175 Hanover Street
`Palo Alto, CA 94304-1130
`(650) 843-5287
`rhyums@cooley.com
`skrumplitsch@cooley.com
`dknauss@cooley.com
`pmao@cooley.com
`aleeper@cooley.com
`lkrickl@cooley.com
`blin@cooley.com
`amwood@cooley.com
`
`Nancy Gettel
`Brian Kao
`Lois Kwasigroch
`AMGEN, INC.
`One Amgen Center Drive
`Thousand Oaks, CA 91320-1799
`(805) 447-1000
`ngettel@amgen.com
`bkao@amgen.com
`loisk@amgen.com
`
`Xiaoxiao Xue
`1299 Pennsylvania Avenue, NW, Suite 700
`Washington, DC 20004-2400
`(202) 842-7809
`xxue@cooley.com
`
`Attorneys for Defendant Amgen Inc.
`
`
`
`Dated: July 19, 2019
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Daniel M. Silver
`Daniel M. Silver (#4758)
`
`
`
`
`
`
`ME1 30984067v.1
`
`2
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
